A background paper on nanotechnology by Germany's Federal Environment Agency earlier this week triggered fearful headlines in some of the country's biggest newspapers. But the agency is now distancing itself from the coverage.
The biological safety of nanotechnology, in other words, how the body reacts to nanoparticles, is a hot topic. Researchers at Lund University in Sweden have managed for the first time to carry out successful experiments involving the injection of so-called nanowires.
Researchers at the Georgia Institute of Technology have won a $6.5 million grant to develop improved components that will boost the efficiency of electric propulsion systems used to control the positions of satellites and planetary probes.
Researchers at the Heinz Nixdorf Chair for Medical Electronics at the Technische Universitaet Muenchen have developed a new test process for cancer drugs. With the help of microchips, they can establish in the laboratory whether a patient's tumor cells will react to a given drug.
Dr. Regina Hoffmann vom Physikalischen Institut des KIT untersucht die Struktur und die elektronischen Eigenschaften von Nanokontakten in der Nanoelektronik und konnte fuer ihr Projekt erstmals fuer Karlsruhe einen begehrten ERC Starting Grant des European Research Council einwerben.
Taking nanomaterials to a new level of structural complexity, scientists have determined how to introduce kinks into arrow-straight nanowires, transforming them into zigzagging two- and three-dimensional structures with correspondingly advanced functions.
A powerful new biosensor developed by European researchers will help identify cells in the immune system that actively suppress tumour growth, then put them to use. Enlisting the patient's own immune system would be like sending reinforcements for resistance fighters.